How to Get GLP-1 in Florida: The Fastest Legal Paths to Wegovy, Zepbound, and Semaglutide in 2026

How Do the Top Florida GLP-1 Providers Actually Compare?

We built this table to answer the question every Florida resident has: What will I actually pay, and what do I actually get?

Most comparison tables online show you the promotional price and nothing else. Ours shows the true monthly cost — membership fees, medication, and what happens after the intro pricing expires.

Prices reflect publicly listed rates as of March 2026. Your actual cost may differ based on dose, medication, and insurance. We verify pricing monthly and update this table when anything changes.

Which Florida GLP-1 Path Fits You Best?

You don't need to read 9,000 words to make a decision. Pick the scenario that sounds like you.

How to Get GLP-1 in Florida: The Step-by-Step Process

Here's exactly what happens from "I'm interested" to "medication in my hand."

Step 1: Confirm You Likely Qualify

Most GLP-1 medications are prescribed for adults who meet these criteria:

• BMI of 30 or higher (classified as obesity), OR
• BMI of 27 or higher with at least one weight-related condition — high blood pressure, Type 2 diabetes, high cholesterol, sleep apnea, PCOS, or cardiovascular disease

Quick BMI Reference for Common Heights

Step 2: Choose Your Provider

Based on the comparison above, pick the path that matches your insurance status, budget, and preferences. We've already done the research — you don't need to compare 15 providers. The table above covers the realistic options for Florida residents.

Step 3: Complete the Online Health Intake

Every legitimate telehealth platform starts with a HIPAA-secured health questionnaire. You'll answer questions about your medical history, current medications, weight, height, and health goals. It takes 5–10 minutes. Some providers (like Ro) include lab work at no additional cost. Others may require it at an added fee ($75–100) or only if clinically needed.

Step 4: Provider Review and Prescription

A Florida-licensed physician, nurse practitioner, or physician assistant reviews your intake. Under Florida Statute §456.47, this telehealth evaluation legally establishes the patient-provider relationship — no in-person visit required. Review timelines vary by provider and demand.

If you're approved, your provider prescribes the appropriate GLP-1 medication and creates a dosing schedule. Everyone starts on a low dose that gradually increases over several weeks. This is called titration, and it's intentional — it minimizes side effects and lets your body adjust.

Step 5: Medication Ships to Your Door

Your prescription is filled by a licensed U.S. pharmacy and either shipped directly to your Florida address in temperature-controlled packaging or sent to a local pharmacy for pickup, depending on the provider, medication, and payment path. If you're using insurance through Ro, the timeline is typically 2–3 weeks (because prior authorization takes time). Cash-pay paths are generally faster.

Step 6: Follow Up and Adjust

Florida's Board of Medicine rule for anti-obesity prescribing (Florida Administrative Code 64B8-9.012) requires re-evaluation at least every three months. Legitimate providers schedule regular check-ins to adjust your dose, manage side effects, and monitor progress. This isn't optional red tape — it's how the medication works best.

Is It Legal to Get GLP-1 Through Telehealth in Florida?

Yes. Unambiguously yes. And here's exactly why.

Florida Statute §456.47 allows licensed healthcare practitioners to evaluate patients, diagnose conditions, and prescribe medications through telehealth — including GLP-1 receptor agonists like semaglutide and tirzepatide. The law permits both synchronous telehealth (live video) and asynchronous methods (like secure questionnaire-based intake).

Here's what matters for Florida residents specifically:

Bottom line: Getting GLP-1 through telehealth in Florida is legal, regulated, and routine. Whether you live in Miami, Tampa, Jacksonville, Orlando, Tallahassee, or rural Panhandle country — the medication ships to you regardless of zip code.

Do I Need an In-Person Exam or Lab Work to Get GLP-1 in Florida?

Not for the initial evaluation. Florida's telehealth law allows providers to conduct the initial patient evaluation entirely online — via video or even secure questionnaire — as long as they determine the telehealth format is sufficient to diagnose and treat.

The practical takeaway: for most Florida residents, the entire GLP-1 process happens online. You don't need to drive anywhere, sit in a waiting room, or take time off work.

How Much Does GLP-1 Actually Cost in Florida? (Every Scenario)

Cost is the number one reason people hesitate. Let's kill the confusion.

If You Have Commercial Insurance

Only about 19% of large employer plans covered GLP-1 medications for weight loss as of 2025. That number is growing, but slowly. Here's how to navigate it:

• If your plan covers GLP-1s: Your copay with a manufacturer savings card could be as low as $0–$25/mo. Novo Nordisk's NovoCare savings tools support Wegovy access; Eli Lilly has a savings card for Zepbound. These cards work with commercial insurance only — not Medicare, Medicaid, or TRICARE.
• If your plan doesn't cover GLP-1s (or you don't know): Ro's insurance concierge will check your coverage for free, submit prior authorization, and fight denials. This alone is worth the membership fee for many people.
• What the insurance fight actually looks like: Your provider documents medical necessity. The insurance concierge submits paperwork. If denied, they appeal. The process takes 2–3 weeks but saves hundreds per month if it works.

If You're Paying Cash (No Insurance)

Here's what each path actually costs — no promo language, just the monthly number:

FDA-approved options:

• Wegovy pill: $149/mo for 1.5mg and 4mg doses (4mg promo runs through April 15, 2026, then $199/mo). Higher doses: $299/mo.
• Wegovy pen (injectable): $199/mo intro for first 2 months at starter doses (0.25mg and 0.5mg only, through March 31, 2026), then $349/mo ongoing.
• Zepbound vial: Lilly's current self-pay pricing lists $299/mo for 2.5mg, $399/mo for 5mg, $499/mo for 7.5mg, and $699/mo for 10/12.5/15mg.
• Ozempic (off-label): New self-pay patients can pay $199/mo for the first 2 fills of 0.25mg or 0.5mg (through March 31, 2026). After that, $349/mo for 0.25–1mg, $499/mo for 2mg through NovoCare.

Compounded options:

• MEDVi: $179/mo first month, $299/mo refills.
• Other compounded providers: $199–$499/mo depending on formulation and dose.

Platform fees (on top of medication):

• Ro: $45 first month, $145/mo after (includes labs, coaching, insurance concierge)
• Hims/Hers: No membership fee, but prepaid plan commitment
• MEDVi: No membership fee
• Walgreens: $49 per visit (no subscription)

The True Total Cost Comparison for Month 1

If You're on Medicare

Big update for 2026: Medicare coverage for GLP-1 weight loss medications is changing. Historically, Medicare was prohibited from covering drugs used for weight loss. That's shifting:

• Medicare GLP-1 Bridge (July–December 2026): CMS announced a short-term demonstration covering Wegovy and Zepbound for eligible Medicare Part D beneficiaries, with a $50/month copay. Eligibility requires BMI of 35+ alone, or BMI of 27+ with additional clinical criteria. This program operates outside the Part D benefit — meaning the $50 copay won't count toward your Part D deductible or out-of-pocket cap.
• BALANCE Model (January 2027): A longer-term CMS model designed to provide ongoing Medicare Part D coverage for GLP-1 medications. Part D plans must opt in, so availability may vary by plan.
• Already-covered uses: If your provider prescribes Wegovy to reduce cardiovascular risk (in adults with established CV disease and obesity/overweight) or Zepbound for obstructive sleep apnea, these uses may already be coverable under your existing Part D benefit — ask your plan.

Until July 2026, cash-pay programs remain the most accessible path for Medicare beneficiaries seeking GLP-1s for weight loss. The manufacturer self-pay pricing above applies.

Source: CMS Medicare GLP-1 Bridge FAQ (cms.gov, updated March 2026); BALANCE Model announcement (December 2025)

If You're on Florida Medicaid

Florida Medicaid coverage for GLP-1 weight loss medications is extremely limited. Some plans may cover GLP-1s for Type 2 diabetes indications — check your specific formulary or call your plan directly. For weight loss specifically, cash-pay telehealth is the most reliable path.

Can You Use HSA or FSA?

GLP-1 medications are generally HSA/FSA eligible, but how you pay depends on the provider. Hims/Hers states that FSA/HSA eligibility varies by plan. Ro currently does not accept HSA/FSA cards directly at checkout, though you may be able to submit receipts for reimbursement — check your plan's rules. Always verify with your plan administrator.

What's the Real Difference Between FDA-Approved and Compounded GLP-1s?

This is the question that separates informed patients from confused ones. The landscape shifted significantly in 2025–2026, and a lot of online content hasn't caught up.

FDA-approved medications — Wegovy, Ozempic, Zepbound, Mounjaro, Rybelsus — have undergone full FDA review for safety, efficacy, and manufacturing quality. When you take Wegovy, you know exactly what's in it, how it was made, and that clinical trials with thousands of patients confirmed its effects.

Compounded GLP-1 medications are prepared by licensed compounding pharmacies (503A or 503B facilities). They are not FDA-approved as finished products and have not been through the same rigorous review process. The FDA does not evaluate compounded medications for safety, effectiveness, or quality before they reach patients.

What this means for you as a Florida patient: If you can afford FDA-approved medication — now starting at $149/mo for the Wegovy pill — that's the safest, most straightforward choice. If cost is genuinely the barrier, compounded options through a vetted provider (licensed pharmacy, licensed prescriber, clear labeling) remain available. But go in with eyes open, verify the pharmacy, and understand you're choosing a different risk profile.

We never want you to choose the cheapest option by default. We want you to choose the right option with full information.

Ro Body: A Strong All-Around Option for Florida Residents Who Want FDA-Approved GLP-1s

If you want one recommendation for the typical Florida resident who's ready to start GLP-1 treatment, Ro Body is where we'd point most people. They solve the two biggest problems — insurance navigation and access to FDA-approved medications at manufacturer-linked pricing — in a way that few competitors match.

What Makes Ro Different

The insurance concierge is the killer feature. Most telehealth GLP-1 providers are cash-only. Ro's team will check your insurance coverage, submit prior authorization requests, and fight denials on your behalf. If you're one of the lucky ones whose plan covers Wegovy or Zepbound, this could save you hundreds per month. If insurance says no, Ro pivots you to cash-pay options at manufacturer-direct pricing — the same prices available through NovoCare or LillyDirect.

FDA-approved medications, period. Ro prescribes Wegovy (pill and injectable), Zepbound (vials), and Ozempic. These are brand-name, FDA-reviewed medications — not compounded alternatives.

Labs included when ordered. If your Ro provider determines you need metabolic lab panels, testing at Quest Diagnostics is included in the membership. Not every patient needs labs on day one, but it's covered when they do.

Structured support. You get 1:1 coaching, nurse check-ins, a 12-month weight loss curriculum, and unlimited provider messaging. For someone new to GLP-1s who wants guidance on side effects, diet adjustments, and dose titration, this matters.

What It Costs

The membership is $45 for your first month, then $145/mo ongoing. Medication is billed separately:

• Wegovy pill: from $149/mo
• Wegovy pen: from $199/mo (intro) → $349/mo
• Zepbound vial: from $299/mo
• Ozempic: from $349/mo

Your true first-month cost with the cheapest path: $194 ($45 membership + $149 Wegovy pill).

The Honest Downside

The membership fee. At $145/mo on top of medication, Ro is not the cheapest option for someone who just wants a refill and nothing else. You're paying for the coaching, labs, and insurance concierge whether you use them all or not. If you're an experienced GLP-1 user who simply needs medication access, there are leaner options.

But here's the thing — for most people starting GLP-1 treatment for the first time, that support is exactly what prevents the two most common failure modes: quitting because of side effects you didn't know how to manage, or stopping because your insurance denied coverage and you didn't know how to fight it.

Real Ro members describe the experience as feeling genuinely supported — from regular check-ins to having someone answer medication questions at midnight. The program is designed to keep you on track, not just ship you a box.

Hims & Hers: Best for Speed and a Polished Digital Experience

If your priority is getting started fast with minimal friction, Hims (for men) and Hers (for women) deliver.

What Makes Them Stand Out

Speed. Complete the intake questionnaire in under five minutes. Provider review is fast. No phone tag, no waiting rooms.

The Novo Nordisk partnership. In March 2026, Hims & Hers announced they were bringing Wegovy and Ozempic directly to their platform through a deal with Novo Nordisk. This is a meaningful shift — it means FDA-approved options alongside their existing product lineup.

Polished app experience. Both Hims and Hers have invested heavily in their mobile app. Unlimited messaging with your care team, prescription management, and progress tracking in one place. Hers in particular is designed around women's health — the onboarding, the content, and the provider communication all reflect that focus.

No membership fee. Unlike Ro, there's no ongoing subscription charge on top of medication. You pay for the treatment plan.

What It Costs

Compounded semaglutide starts from $199/mo on prepaid plans. FDA-approved options (Wegovy, Ozempic, Zepbound) are available at varying price points. HSA/FSA reimbursement may vary by plan.

The Honest Downside

Best pricing often requires multi-month prepay — Hims has offered 2-, 4-, and 6-month plan options for various products. If you want true month-to-month flexibility, this isn't ideal. Check current terms and cancellation policy on their site before committing. Some users report it takes persistence to reach support for plan changes.

Also worth noting: Hims states that GLP-1 medications are not available in all 50 states. Verify Florida availability on their website before starting intake.

That said, for someone who values a clean app interface, fast onboarding, and doesn't mind committing to a few months — Hims and Hers are genuinely good options, especially with the new FDA-approved access.

MEDVi: The Budget Path (With Important Caveats)

MEDVi consistently shows up as one of the most affordable GLP-1 telehealth options online, and for good reason — the pricing is genuinely lower than most competitors.

What You Get

A licensed provider evaluates you through the OpenLoop Health network. If approved, you're prescribed a compounded GLP-1 medication shipped from a licensed U.S. pharmacy. Month-to-month, no contract, no hidden membership fees. Unlimited messaging with your care team and 24/7 support.

First month: $179 all-in. Refills: $299/mo.

The Honest Downside

MEDVi's medications are compounded — not FDA-approved as finished products. We've explained what that means in our compounded vs. FDA-approved section above, and we strongly recommend reading it before choosing this path.

There's no insurance support — this is a cash-only path. If you want brand-name Wegovy or Zepbound, MEDVi isn't the provider for you. And with the Wegovy pill now starting at $149/mo through manufacturer programs, the price gap between FDA-approved and compounded has narrowed considerably. Verify the pharmacy, clinician licensure, and follow-up care details on MEDVi's site before paying.

Who Should Consider MEDVi

Someone who has already read the compounded section above, understands the tradeoffs, and still prefers the lower price point. Someone who wants month-to-month flexibility without a prepaid commitment. Someone who's been on GLP-1s before and needs straightforward medication access without the bells and whistles.

Don't Overlook Your Local Florida Doctor

We're a telehealth-focused site, so it might surprise you that we're recommending a local doctor. But for some Florida residents, it's genuinely the best path.

• If your insurance might pay, a local physician can submit to insurance directly, handle prior authorization through their own billing team, and prescribe brand-name GLP-1s that get filled at your neighborhood pharmacy. For someone with good insurance and a willing PCP, this could be the cheapest option long-term.
• If you have multiple health conditions, an in-person provider can do a full workup — blood pressure, labs, EKG, review your entire medication list — and manage your GLP-1 prescription alongside everything else.
• If you want continuity, a local doctor-patient relationship offers something telehealth can't replicate: a provider who knows your full history, sees you quarterly (as Florida law requires for anti-obesity prescribing), and adjusts your treatment based on the whole picture.

The downside: it's slower. You'll need to schedule an appointment, potentially wait weeks, and handle pharmacy logistics yourself. But for the right person, it's the right choice.

You can verify any Florida physician's license through the Florida Department of Health MQA Portal at mqa-internet.doh.state.fl.us.

Who Should NOT Pick Each Path? (The Honest Tradeoff Matrix)

We've told you who each provider is best for. Now here's who should actively avoid each one. This is the part most affiliate sites won't write — but it's the part that actually helps you decide.

Nobody is "best for everyone." Anyone who tells you otherwise is selling, not helping.

Wegovy vs. Ozempic vs. Zepbound vs. Mounjaro: Which GLP-1 Medication Is Best?

This section exists because you're going to wonder about it — and if we don't answer it here, you'll go back to searching. So let's settle it.

Wegovy (semaglutide — for weight loss)

Wegovy is FDA-approved specifically for chronic weight management. It's the most-studied GLP-1 for weight loss, with the landmark STEP trials showing an average 15% body weight reduction over 68 weeks. Available as both a once-weekly injection and a daily pill (FDA approved oral Wegovy on December 22, 2025; it became available in early January 2026). The starting dose is low (0.25mg injection or 1.5mg pill) and increases gradually over several months.

Best for: Someone whose primary goal is weight loss and who wants the medication with the most weight-management-specific clinical data behind it.

Cost without insurance: Pill from $149/mo. Pen from $199/mo (promo) → $349/mo ongoing.

Ozempic (semaglutide — for Type 2 diabetes)

Ozempic contains the same active ingredient as Wegovy (semaglutide) but is FDA-approved for Type 2 diabetes, not weight loss. Clinicians can and do prescribe it off-label for weight management — this is legal and common, but the approved doses are lower than Wegovy's weight-loss doses.

Best for: Someone who has Type 2 diabetes and also wants weight management benefits. Some providers prescribe Ozempic off-label for weight loss when Wegovy isn't available or affordable.

Cost without insurance: $349/mo for 0.25–1mg doses, $499/mo for 2mg through NovoCare.

Zepbound (tirzepatide — for weight loss)

Zepbound is Eli Lilly's FDA-approved weight loss medication. It's a dual GIP/GLP-1 receptor agonist — meaning it targets two hormones instead of one. The SURMOUNT clinical trials showed average weight loss of 15–22% of body weight, making it among the most effective options currently available. Injectable only, once weekly.

Best for: Someone who wants the highest potential weight loss and is okay with the injectable format. Some providers consider it when semaglutide hasn't produced the desired results.

Cost without insurance: Vials from $299/mo (2.5mg) through LillyDirect or Ro.

Mounjaro (tirzepatide — for Type 2 diabetes)

Same active ingredient as Zepbound, but FDA-approved for Type 2 diabetes. Like the Ozempic/Wegovy relationship, Mounjaro may be prescribed off-label for weight loss.

Best for: Someone with Type 2 diabetes who also wants weight management benefits from the tirzepatide mechanism.

Quick Medication Comparison

*These figures come from different trials with different patient populations and are not head-to-head comparisons. Individual results vary.

Your provider will recommend the right medication based on your health profile, insurance situation, and goals. You don't have to pick — that's their job.

How to Verify a Florida GLP-1 Provider Before You Pay

This section might save you more than anything else on this page. The GLP-1 telehealth space has exploded, and not every provider deserves your trust or your money.

Before you pay any provider — whether it's one we recommend or one you found on your own — run through these checks:

What About Side Effects? The Honest Truth.

Let's address this head-on, because it's probably one of the reasons you're still reading instead of already signing up.

The most common side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation, stomach upset, headache, dizziness, and fatigue are among the most commonly reported per FDA prescribing information. Nausea is the most frequent, especially in the first few weeks. That sounds concerning until you understand the context:

Source: Wegovy FDA prescribing information (NDA 215256); Zepbound FDA prescribing information (NDA 217806)

What About Weight Regain?

Here's the part most GLP-1 ads conveniently skip: if you stop the medication without building sustainable lifestyle habits, weight regain is likely. Research consistently shows this. It's not a failure of the drug — it's biology. GLP-1 is most effective as a long-term tool paired with nutritional and exercise changes, not a short-term fix.

But here's what that actually means in practice: patients who stay on treatment and pair it with even modest lifestyle changes see results that weren't possible with diet and exercise alone. Real patients describe the experience not as white-knuckling through hunger, but as finally having the constant mental negotiation with food go quiet.

As one Ro Body member put it: more energy, better physical stamina, and feeling genuinely supported by regular check-ins with a care team. (Note: Ro members were paid for their testimonials.)

That's not a diet trick. That's a medical intervention working as designed. The program is designed to keep you on track, not just ship you a box.

What to Expect During Your First Month on GLP-1

Knowing what's coming makes the first month dramatically easier. Here's the honest week-by-week reality most Florida patients experience.

Why Are So Many Florida Residents Turning to GLP-1?

Florida isn't just a big state — it's a state where the need for accessible weight loss treatment is acute.

The Florida Department of Health estimates obesity will cost the state nearly $34 billion annually over the next 20 years (American Diabetes Association, Florida obesity brief, 2025). Florida's self-reported adult obesity prevalence is 29.6% as of the 2024 BRFSS data (America's Health Rankings) — but a 2018 University of Florida study using clinical records from the OneFlorida Data Trust found the actual measured rate was closer to 37.1% when based on objective height and weight data rather than self-reported surveys. People tend to under-report their weight on phone surveys. The clinical reality is likely higher than the headline number.

Florida's large 65+ population — more than 20% of residents — drives demand, but Medicare's limited GLP-1 coverage leaves many seniors paying out of pocket. Florida's diverse communities (27% Hispanic/Latino population) also create demand for multilingual telehealth access, which the major national platforms increasingly support.

At the same time, Florida's telehealth laws are among the most permissive in the country for GLP-1 prescribing. No in-person visit required. No controlled substance barriers. Clear registration pathways for out-of-state providers. This combination — high need plus accessible legal framework — is why Florida has become one of the most active markets for GLP-1 telehealth.

How We Evaluated Florida GLP-1 Options

We research every provider on this page using seven criteria. We think you should know what they are, because it lets you evaluate any provider we don't cover.

1. Medication legitimacy. Is it FDA-approved, prescribed off-label, or compounded? We separate these clearly because they are not the same.
2. Florida legal compliance. Is the provider licensed or registered for Florida telehealth? Do they follow Florida's anti-obesity prescribing rules?
3. True cost transparency. We calculate total monthly cost — membership, medication, labs, shipping — not just the promotional headline.
4. Insurance support. Does the provider help navigate insurance coverage, prior authorization, and appeals?
5. Clinical oversight quality. How often do you hear from a provider? Is follow-up built in or optional?
6. Pharmacy verification. Can we verify the dispensing pharmacy through the Florida Board of Pharmacy and NABP?
7. Cancel flexibility. Can you stop month-to-month, or are you locked in?

We verify pricing monthly and date-stamp every data point. When a provider changes their pricing or policies, we update within a week.

Affiliate disclosure: We earn commissions from some providers linked on this page. This does not influence our rankings, recommendations, or the inclusion of non-affiliate benchmarks (like Walgreens and local doctors). If we stripped every affiliate link from this page, the advice wouldn't change.

Your Next Step

You've done the research. You understand the options, the costs, the Florida rules, and the tradeoffs. The only question left is whether you medically qualify — and the only way to find out is to take the first step.

Each provider above has its own intake process. Some start with a free eligibility screener; others charge a visit fee upfront (Walgreens charges $49 per visit, for example). Review the pricing before you start — we've laid it all out above so there are no surprises.

Florida makes this as easy as any state in the country. The telehealth laws are clear. The providers are licensed. The medications are backed by some of the most robust clinical evidence in modern medicine. The hardest part was the decision to look into it — and you've already done that.

You deserve to know what it feels like to have energy again. To stop negotiating with hunger every hour. To get bloodwork that makes your doctor smile. That's what the clinical evidence supports, and it starts with choosing the path that fits your situation.

Tools Coming Soon for Florida GLP-1 Patients

We don't just write about this — we're building interactive tools to make the decision even easier. Here's what's in development:

• Florida GLP-1 Path Finder Quiz (coming soon) — Answer 5 questions about your insurance, budget, medication preference, and timeline. Get matched to the right provider in 60 seconds. No email required.
• Real Monthly Cost Calculator (coming soon) — Input your provider, medication, and dose. See the true monthly cost including membership fees, medication, labs, and shipping — plus the projected 6-month total.
• Florida Provider Legitimacy Checker (coming soon) — Paste a provider's website URL and we walk you through verifying their Florida license, telehealth registration, pharmacy accreditation, and medication transparency.

Bookmark this page — we'll update it as each tool goes live.

Florida GLP-1: Frequently Asked Questions

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. Individual results vary. Side effects and contraindications may apply — consult your provider before starting treatment.

Sources: FDA Prescribing Information — Wegovy (NDA 215256), Zepbound (NDA 217806), Wegovy tablets (NDA 218316); Florida Statute §456.47; Florida Administrative Code 64B8-9.012; FDA GLP-1 compounding guidance (2025); Wilding JPH et al., NEJM 2021 (STEP 1); Jastreboff AM et al., NEJM 2022 (SURMOUNT-1); Cochrane Reviews (2025); Hims & Hers/Novo Nordisk partnership (SEC filing, March 2026); Ro pricing (ro.co, verified March 2026); Walgreens Weight Management (walgreens.com, verified March 2026); NovoCare savings offers; Zepbound savings (lilly.com); CMS Medicare GLP-1 Bridge FAQ; CMS BALANCE Model; America's Health Rankings — Florida BRFSS 2024; American Diabetes Association — Florida obesity brief (2025); Florida DOH MQA Portal; Florida Telehealth Registration.